NM_020822.3:c.2427G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020822.3(KCNT1):​c.2427G>A​(p.Thr809Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.676 in 1,613,708 control chromosomes in the GnomAD database, including 372,007 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 32274 hom., cov: 33)
Exomes 𝑓: 0.68 ( 339733 hom. )

Consequence

KCNT1
NM_020822.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -3.94

Publications

22 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 9-135777415-G-A is Benign according to our data. Variant chr9-135777415-G-A is described in ClinVar as Benign. ClinVar VariationId is 129357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.94 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
NM_020822.3
MANE Select
c.2427G>Ap.Thr809Thr
synonymous
Exon 21 of 31NP_065873.2Q5JUK3-3
KCNT1
NM_001272003.2
c.2292G>Ap.Thr764Thr
synonymous
Exon 20 of 31NP_001258932.1Q5JUK3-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
ENST00000371757.7
TSL:1 MANE Select
c.2427G>Ap.Thr809Thr
synonymous
Exon 21 of 31ENSP00000360822.2Q5JUK3-3
KCNT1
ENST00000460750.5
TSL:1
n.*2037G>A
non_coding_transcript_exon
Exon 21 of 32ENSP00000418777.1F8WC49
KCNT1
ENST00000460750.5
TSL:1
n.*2037G>A
3_prime_UTR
Exon 21 of 32ENSP00000418777.1F8WC49

Frequencies

GnomAD3 genomes
AF:
0.647
AC:
98304
AN:
151916
Hom.:
32246
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.567
Gnomad AMI
AF:
0.796
Gnomad AMR
AF:
0.663
Gnomad ASJ
AF:
0.488
Gnomad EAS
AF:
0.588
Gnomad SAS
AF:
0.751
Gnomad FIN
AF:
0.766
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.679
Gnomad OTH
AF:
0.613
GnomAD2 exomes
AF:
0.668
AC:
167817
AN:
251278
AF XY:
0.671
show subpopulations
Gnomad AFR exome
AF:
0.557
Gnomad AMR exome
AF:
0.659
Gnomad ASJ exome
AF:
0.496
Gnomad EAS exome
AF:
0.592
Gnomad FIN exome
AF:
0.764
Gnomad NFE exome
AF:
0.675
Gnomad OTH exome
AF:
0.645
GnomAD4 exome
AF:
0.679
AC:
993200
AN:
1461674
Hom.:
339733
Cov.:
53
AF XY:
0.681
AC XY:
495342
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.562
AC:
18818
AN:
33470
American (AMR)
AF:
0.658
AC:
29417
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.491
AC:
12835
AN:
26124
East Asian (EAS)
AF:
0.576
AC:
22863
AN:
39698
South Asian (SAS)
AF:
0.738
AC:
63674
AN:
86254
European-Finnish (FIN)
AF:
0.766
AC:
40883
AN:
53406
Middle Eastern (MID)
AF:
0.507
AC:
2923
AN:
5766
European-Non Finnish (NFE)
AF:
0.686
AC:
762405
AN:
1111874
Other (OTH)
AF:
0.652
AC:
39382
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
17187
34374
51560
68747
85934
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19484
38968
58452
77936
97420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.647
AC:
98378
AN:
152034
Hom.:
32274
Cov.:
33
AF XY:
0.651
AC XY:
48364
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.567
AC:
23506
AN:
41432
American (AMR)
AF:
0.663
AC:
10139
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.488
AC:
1692
AN:
3470
East Asian (EAS)
AF:
0.588
AC:
3030
AN:
5156
South Asian (SAS)
AF:
0.751
AC:
3617
AN:
4818
European-Finnish (FIN)
AF:
0.766
AC:
8123
AN:
10608
Middle Eastern (MID)
AF:
0.429
AC:
126
AN:
294
European-Non Finnish (NFE)
AF:
0.679
AC:
46121
AN:
67946
Other (OTH)
AF:
0.616
AC:
1300
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1840
3679
5519
7358
9198
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.656
Hom.:
72215
Bravo
AF:
0.630
Asia WGS
AF:
0.667
AC:
2320
AN:
3478
EpiCase
AF:
0.659
EpiControl
AF:
0.642

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
2
not provided (2)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Developmental and epileptic encephalopathy, 14 (1)
-
-
1
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
1.0
DANN
Benign
0.84
PhyloP100
-3.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs914428; hg19: chr9-138669261; COSMIC: COSV53696861; COSMIC: COSV53696861; API